A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs | |
Lu, S.2; Zhang, Y.3; Zhang, G.4; Zhou, J.5; Cang, S.6; Cheng, Y.7; Wu, G.8; Cao, P.9; Lv, D.1; Jian, H.2 | |
刊名 | JOURNAL OF THORACIC ONCOLOGY |
2022-09-01 | |
卷号 | 17 |
关键词 | third-generation EGFR-TKI befotertinib T790M |
ISSN号 | 1556-0864 |
WOS研究方向 | Oncology ; Respiratory System |
语种 | 英语 |
出版者 | ELSEVIER SCIENCE INC |
WOS记录号 | WOS:000858678101268 |
内容类型 | 期刊论文 |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/129941] |
专题 | 中国科学院合肥物质科学研究院 |
作者单位 | 1.Taizhou Hosp Zhejiang Prov, Linhai, Peoples R China 2.Shanghai Chest Hosp, Shanghai, Peoples R China 3.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China 4.Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China 5.Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou, Peoples R China 6.Henan Prov Peoples Hosp, Zhengzhou, Peoples R China 7.Jilin Canc Hosp, Changchun, Peoples R China 8.Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China 9.Cent South Univ, Xiangya Hosp 3, Changsha, Peoples R China 10.Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China |
推荐引用方式 GB/T 7714 | Lu, S.,Zhang, Y.,Zhang, G.,et al. A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs[J]. JOURNAL OF THORACIC ONCOLOGY,2022,17. |
APA | Lu, S..,Zhang, Y..,Zhang, G..,Zhou, J..,Cang, S..,...&Zhang, S..(2022).A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs.JOURNAL OF THORACIC ONCOLOGY,17. |
MLA | Lu, S.,et al."A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs".JOURNAL OF THORACIC ONCOLOGY 17(2022). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论